Role of α2-agonists in the treatment of acute alcohol withdrawal.
about
Elevated Norepinephrine may be a Unifying Etiological Factor in the Abuse of a Broad Range of Substances: Alcohol, Nicotine, Marijuana, Heroin, Cocaine, and CaffeineMorphine for Intravenous Patient-Controlled Analgesia May Inhibit Delirium Tremens: A Case Report and Literature ReviewEffects of alcohol dependence and withdrawal on stress responsiveness and alcohol consumptionEfficacy and safety of pregabalin in the treatment of alcohol and benzodiazepine dependencePharmacological strategies for detoxification.The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup.Novel use of dexmedetomidine for the treatment of anticholinergic toxidrome.Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?Addition of dexmedetomidine to benzodiazepines for patients with alcohol withdrawal syndrome in the intensive care unit: a randomized controlled study.Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICUAdrenergic Inhibition with Dexmedetomidine to Treat Stress Cardiomyopathy during Alcohol Withdrawal: A Case Report and Literature Review.Treatment of Alcohol Withdrawal Syndrome with and without DexmedetomidineIdentification and management of alcohol withdrawal syndromeAlcohol withdrawal and delirium tremens in the critically ill: a systematic review and commentary.A case-based approach to the practical application of dexmedetomidine in critically ill adults.Perioperative temperature elevation: not all hyperthermia is malignant hyperthermia.Dexmedetomidine for the treatment of alcohol withdrawal syndrome: rationale and current status of research.Evaluation of dexmedetomidine therapy for sedation in patients with toxicological events at an academic medical center.Evaluating the effects of dexmedetomidine compared to propofol as adjunctive therapy in patients with alcohol withdrawal.Dexmedetomidine for Alcohol Withdrawal Syndrome.Approach to the Complicated Alcohol Withdrawal Patient.Neurobiology of comorbid post-traumatic stress disorder and alcohol-use disorder.Involvement of delta opioid receptors in alcohol withdrawal-induced mechanical allodynia in male C57BL/6 mice.Genetic Variation in the Vesicular Monoamine Transporter 1 (VMAT1/SLC18A1) Gene and Alcohol Withdrawal Severity.Dexmedetomidine for acute baclofen withdrawal.Alcoholic delirium tremens with hollow viscus perforation scheduled for emergency laparotomy.Dexmedetomidine impairs success of patient-controlled sedation in alcoholics during ERCP: a randomized, double-blind, placebo-controlled study.Inpatient management of acute alcohol withdrawal syndrome.Role of cortical alpha-2 adrenoceptors in alcohol withdrawal-induced depression and tricyclic antidepressants.Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines.[Dexmedetomidine in the treatment of acute alcohol withdrawal delirium].Adaptation of the Pharmacological Management of Delirium in ICU Patients in Iran: Introduction and Definition.Treatment of Severe Alcohol Withdrawal: A Focus on Adjunctive Agents.Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework
P2860
Q24608522-B140EF70-16B7-4A8F-8197-5D1FBEFC0B84Q26778030-5B0A2980-39E0-4097-959A-4DD3457DD967Q26825434-CCFBE904-E3F5-43BF-914A-AABCE86AF5F6Q28266198-8E146F23-27EE-485F-B96D-02F388C965CAQ33582092-F69B7BEF-1146-4B0A-88AE-B192B98797B7Q34264716-70080012-88E7-4763-AB4C-5303F9F500C0Q34613285-A426ABDE-5BEF-49FD-8746-96385E87CF7EQ34613312-2298C0B6-498B-41CF-B7DE-433D4AEC337DQ36241022-3484F340-0EF1-4F0B-BB87-4471C8A5F199Q36297368-9B003238-8A6E-4B5E-875F-667E536B90F0Q36666016-180571D9-F8DB-499A-BB59-88840CEEFC1AQ36903563-03E611EE-C798-4D1D-A37D-D86C2F3AA3C5Q37161994-1445579F-0C75-4FF3-BD23-DD3D0598C065Q38062830-40ED599B-ECF6-4566-8D3C-A83148C1DD62Q38079560-BF367A4D-9E49-4065-8972-0F8C33EAA5E5Q38124469-FD0EF688-0B68-4D2F-9644-5E0BD0D4130EQ38131455-460959C3-32B0-40E2-8A60-1B3865F9B119Q38209048-369B0128-23BA-422F-A0F5-F21815F2C80EQ38266452-06CD54A7-BBE4-467E-B382-6828A29D30A3Q38591896-90229407-902C-484C-AFF6-171434708FBFQ38620815-47541BDD-680E-43AA-BC83-B428E8C1FE03Q38982604-DF0BC536-BF29-498F-B2C4-5C62F15A62FBQ39168054-A611C332-BB83-4C95-9CB1-03D1285E6AA4Q39997247-27848BEB-3C34-466A-A8C1-81D1C804F11DQ41658188-0443D726-90B7-4F13-8969-9169057D903CQ41961335-58DD9EDE-67DB-4FE8-B952-0614EDA28513Q44837361-7EF00B94-A3E5-4474-A0D7-E2752600EBAAQ45263185-2AF9A426-B073-438A-837B-7C37A212BA17Q47791795-03994A2B-FE3E-43CA-8650-BE592F605B44Q47861743-6B3B6A9B-040D-46E7-8314-F4142FB87F79Q54651541-8E7DD57D-5024-4E4F-B751-AD2B0BBEED1AQ55006460-F04DA62C-35D4-42F2-94A7-158AEE69A889Q55263124-75B7C333-CB77-485B-AA2E-E647BC757BDFQ58788199-F4A4BDAA-7B38-40C9-A8FB-164C861849A5
P2860
Role of α2-agonists in the treatment of acute alcohol withdrawal.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of α2-agonists in the treatment of acute alcohol withdrawal.
@en
Role of α2-agonists in the treatment of acute alcohol withdrawal.
@nl
type
label
Role of α2-agonists in the treatment of acute alcohol withdrawal.
@en
Role of α2-agonists in the treatment of acute alcohol withdrawal.
@nl
prefLabel
Role of α2-agonists in the treatment of acute alcohol withdrawal.
@en
Role of α2-agonists in the treatment of acute alcohol withdrawal.
@nl
P2093
P2860
P356
P1476
Role of α2-agonists in the treatment of acute alcohol withdrawal.
@en
P2093
Allison Chilipko
Andrew J Muzyk
Daryn K Norwood
Jill A Fowler
P2860
P304
P356
10.1345/APH.1P575
P407
P577
2011-04-26T00:00:00Z